Mexidol, Cytoflavin, and succinic acid derivatives as antihypoxic, anti-ischemic metabolic modulators, and ergogenic aids in athletes and consideration of their potential as performance enhancing drugs
Emoxypine (ethylmethylhydroxypyridine) is a synthetic derivative of vitamin B . Emoxypine succinate is a registered drug in Russia and Ukraine under various trade names including Mexidol, Mexicor, and Armadin Long. Mexidol demonstrates antihypoxic and anti-ischemic effects and also modulates metabol...
Saved in:
Published in | Drug testing and analysis Vol. 16; no. 12; p. 1436 |
---|---|
Main Authors | , , , |
Format | Journal Article |
Language | English |
Published |
England
01.12.2024
|
Subjects | |
Online Access | Get more information |
Cover
Loading…
Abstract | Emoxypine (ethylmethylhydroxypyridine) is a synthetic derivative of vitamin B
. Emoxypine succinate is a registered drug in Russia and Ukraine under various trade names including Mexidol, Mexicor, and Armadin Long. Mexidol demonstrates antihypoxic and anti-ischemic effects and also modulates metabolism. The use of Mexidol by Russian athletes has been confirmed in the past. Current use by athletes is unknown as this drug is not monitored or included in drug testing protocol. Metabotropic and antihypoxic effects of Mexidol were compared to the effects of meldonium or trimetazidine, both of which are included on the World Anti-Doping Agency (WADA) Prohibited List in category S4.4. Metabolic Modulators. The conjugation of emoxypine with succinate elevates the therapeutic effectiveness of the Mexidol formulation as succinic acid itself has important impacts to consider despite being a common food additive and drug excipient. Other succinic acid salts like ammonium succinate, found as dietary supplement, have been patented as performance enhancers. Available research on healthy subjects suggests that combinations of selected 3-substituted pyridine derivatives with succinate including Mexidol and a related drug Cytoflavin can enhance the performance of athletes. Cytoflavin is a multi-component formula containing meglumine sodium succinate, nicotinamide (vitamin B
), inosine (riboxin), and riboflavin. Other related succinate-based drugs include Remaxol, Reamberin, and Cogitum. Mexidol and Cytoflavin and related substances exhibit similar biological effects as drugs on the WADA Prohibited List, and if they are used for performance enhancement by athletes, they could be worthy of consideration as prohibited substances in sport. |
---|---|
AbstractList | Emoxypine (ethylmethylhydroxypyridine) is a synthetic derivative of vitamin B
. Emoxypine succinate is a registered drug in Russia and Ukraine under various trade names including Mexidol, Mexicor, and Armadin Long. Mexidol demonstrates antihypoxic and anti-ischemic effects and also modulates metabolism. The use of Mexidol by Russian athletes has been confirmed in the past. Current use by athletes is unknown as this drug is not monitored or included in drug testing protocol. Metabotropic and antihypoxic effects of Mexidol were compared to the effects of meldonium or trimetazidine, both of which are included on the World Anti-Doping Agency (WADA) Prohibited List in category S4.4. Metabolic Modulators. The conjugation of emoxypine with succinate elevates the therapeutic effectiveness of the Mexidol formulation as succinic acid itself has important impacts to consider despite being a common food additive and drug excipient. Other succinic acid salts like ammonium succinate, found as dietary supplement, have been patented as performance enhancers. Available research on healthy subjects suggests that combinations of selected 3-substituted pyridine derivatives with succinate including Mexidol and a related drug Cytoflavin can enhance the performance of athletes. Cytoflavin is a multi-component formula containing meglumine sodium succinate, nicotinamide (vitamin B
), inosine (riboxin), and riboflavin. Other related succinate-based drugs include Remaxol, Reamberin, and Cogitum. Mexidol and Cytoflavin and related substances exhibit similar biological effects as drugs on the WADA Prohibited List, and if they are used for performance enhancement by athletes, they could be worthy of consideration as prohibited substances in sport. |
Author | Stewart, Timothy Jędrejko, Karol Catlin, Oliver Muszyńska, Bożena |
Author_xml | – sequence: 1 givenname: Karol orcidid: 0000-0001-5301-2396 surname: Jędrejko fullname: Jędrejko, Karol organization: Faculty of Pharmacy, Department of Pharmaceutical Botany, Jagiellonian University Medical College, Kraków, Poland – sequence: 2 givenname: Oliver surname: Catlin fullname: Catlin, Oliver organization: Banned Substances Control Group (BSCG), Los Angeles, California, USA – sequence: 3 givenname: Timothy surname: Stewart fullname: Stewart, Timothy organization: Banned Substances Control Group (BSCG), Los Angeles, California, USA – sequence: 4 givenname: Bożena surname: Muszyńska fullname: Muszyńska, Bożena organization: Faculty of Pharmacy, Department of Pharmaceutical Botany, Jagiellonian University Medical College, Kraków, Poland |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/38403950$$D View this record in MEDLINE/PubMed |
BookMark | eNo1kNtqwzAMhs3YWA8b7AmGH6DpnDhJm8tRdoKO3WzXRbHlxiOxg-2U9hH3VnPbDQSSkPg--Cfk0liDhNylbJ4ylj3IAHNeFsUFGadVniWLMk1HZOL9N2NlnvHimoz4Mme8KtiY_LzjXkvbzujqEKxqYafNjIKR1A9CaKMFBaEllej0DoLeoacQywTdHHq712J2WhLtRYNdfO8wQG3b42Tl0EKwzp-J6LZ2iyeklp5qQyE0LYYjMp6FNV5HT7RYQ62ioUHtaG8DRgG0R2-PTlnXgRFI0TSxa7Ol0g1bf0OuFLQeb__6lHw9P32uXpP1x8vb6nGdCL7kRSLkcpGrOl2qagFMsRLqLIbBC8ixElVV1yqHBRdCxoQAMa9QyTytBZepLLMym5L7M7cf6g7lpne6A3fY_Gea_QIRx34m |
CitedBy_id | crossref_primary_10_1007_s00424_024_02981_6 crossref_primary_10_3390_antiox14010108 crossref_primary_10_31718_2077_1096_24_4_155 crossref_primary_10_3390_foods14050772 |
ContentType | Journal Article |
Copyright | 2024 John Wiley & Sons Ltd. |
Copyright_xml | – notice: 2024 John Wiley & Sons Ltd. |
DBID | CGR CUY CVF ECM EIF NPM |
DOI | 10.1002/dta.3655 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) |
DatabaseTitleList | MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | no_fulltext_linktorsrc |
Discipline | Pharmacy, Therapeutics, & Pharmacology |
EISSN | 1942-7611 |
ExternalDocumentID | 38403950 |
Genre | Journal Article Review |
GroupedDBID | --- 05W 0R~ 1OC 31~ 33P 4.4 53G 5DZ 5GY 8-0 8-1 A00 AAESR AAHHS AAHQN AAMNL AANHP AANLZ AAYCA AAZKR ABCUV ABJNI ACBWZ ACCFJ ACCZN ACGFS ACPOU ACRPL ACXQS ACYXJ ADBBV ADKYN ADNMO ADXAS ADZMN ADZOD AEEZP AEIGN AENEX AEQDE AEUYR AFBPY AFFPM AFWVQ AHBTC AHMBA AITYG AIURR AIWBW AJBDE ALMA_UNASSIGNED_HOLDINGS ALUQN ALVPJ AMYDB ASPBG AVWKF AZFZN AZVAB BDRZF BFHJK BMXJE BRXPI CGR CUY CVF DCZOG DU5 EBD EBS ECM EIF EJD EMOBN F5P FEDTE G-S GODZA HGLYW HVGLF HZ~ LATKE LEEKS LH4 LITHE LOXES LUTES LW6 LYRES MEWTI MK0 MY. MY~ NNB NPM O9- OIG P2P P2W P4E PQQKQ ROL SUPJJ SV3 TUS WBKPD WOHZO WXSBR WYJ XV2 ZZTAW |
ID | FETCH-LOGICAL-c3835-cd874fb18f97a0f06ab240335a4e9c99bbf4a73ccd039aee49efd41bc3d1d6262 |
IngestDate | Wed Jan 15 06:03:32 EST 2025 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 12 |
Keywords | antihypoxants Cytoflavin metabolic modulators Mexidol actoprotectors |
Language | English |
License | 2024 John Wiley & Sons Ltd. |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c3835-cd874fb18f97a0f06ab240335a4e9c99bbf4a73ccd039aee49efd41bc3d1d6262 |
ORCID | 0000-0001-5301-2396 |
OpenAccessLink | https://ruj.uj.edu.pl/xmlui/handle/item/327012 |
PMID | 38403950 |
ParticipantIDs | pubmed_primary_38403950 |
PublicationCentury | 2000 |
PublicationDate | 2024-Dec |
PublicationDateYYYYMMDD | 2024-12-01 |
PublicationDate_xml | – month: 12 year: 2024 text: 2024-Dec |
PublicationDecade | 2020 |
PublicationPlace | England |
PublicationPlace_xml | – name: England |
PublicationTitle | Drug testing and analysis |
PublicationTitleAlternate | Drug Test Anal |
PublicationYear | 2024 |
SSID | ssj0064235 |
Score | 2.3736978 |
SecondaryResourceType | review_article |
Snippet | Emoxypine (ethylmethylhydroxypyridine) is a synthetic derivative of vitamin B
. Emoxypine succinate is a registered drug in Russia and Ukraine under various... |
SourceID | pubmed |
SourceType | Index Database |
StartPage | 1436 |
SubjectTerms | Athletes Doping in Sports - prevention & control Flavin Mononucleotide - pharmacology Humans Inosine Diphosphate - pharmacology Male Methylhydrazines - pharmacology Performance-Enhancing Substances - pharmacology Picolines - pharmacology Succinates - pharmacology Succinic Acid |
Title | Mexidol, Cytoflavin, and succinic acid derivatives as antihypoxic, anti-ischemic metabolic modulators, and ergogenic aids in athletes and consideration of their potential as performance enhancing drugs |
URI | https://www.ncbi.nlm.nih.gov/pubmed/38403950 |
Volume | 16 |
hasFullText | |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnZ3fb9MwEMetFRDaC-L3b-QHtpc2o0lcd36EApqQgD100t4mx3a2sDWu2nRa9x_yX3FnOz82DQRIVdTGrRv1PnJ817vvEfI2H-tYxiyO4OYxjlgcm0hoYFmJoQB3DBtNOrXPb3zvgH05HB1u9O50spZWVbajLm-sK_kfq8I5sCtWyf6DZZtJ4QQ8B_vCESwMx7-y8VdzUWjfImuyrmx-Js-9JICLhq-UwqrHvlSF7mu4nnMn8r3E1jLwexYn67m9KJR_f1VEBTi6LlV-ZipAA9WvZ1Zjey_r-6jhrGZxbOF6cNrC59K6dAyM3voKOd__s9mI-j8i5rbCrCTUJViiUnJTq2DKExT8KI_7erEKIfuwVf4IJ_oVioCEMkoZ9FOapB_cCAuhF-bHqQ2FbbZJGJnIKvSi_36GuSdNKAmjhb5OKXDaMre8XG9NRlu7bHnqO1JbfPlhYnyL8To6krBOponxK7pg4ELwsKLXSz7vop10FnDYPvIb7yxeqVZXciflXli4A9h85ghLwVtOhRfS_fPoNY3veqhHeuDtYPtWjDn5_QQ4iOmolk0eJu_qS9gkd-uPXXOJ3NZoep_cCz4Nfe8BfUA2TPmQbO97UfT1gE7bGr_lgG7T_VYuff2I_AwUD2jL8ICCwWlNMEWCaYdgKuHREjygV_ilDb-05dfP2NBLkV5alLSm1w1foZfanDp6aUMvfm-HXtrQSx29j8nB50_TyV4UGoxEKgXPI1KwKrE8i3dzMZbDfMhlhvKU6UgyI5QQWZYzOU6V0vAzS2OYMLlmcaZSHWue8OQJuVXa0jwjdBTzTOUyTROFpe1McJXpjDFjhFZ8yJ6Tp95ER3OvInNUG-_Fb0deks0W6Vfkdg7LlnkNe-Aqe-MQ-QVSYby0 |
linkProvider | National Library of Medicine |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Mexidol%2C+Cytoflavin%2C+and+succinic+acid+derivatives+as+antihypoxic%2C+anti-ischemic+metabolic+modulators%2C+and+ergogenic+aids+in+athletes+and+consideration+of+their+potential+as+performance+enhancing+drugs&rft.jtitle=Drug+testing+and+analysis&rft.au=J%C4%99drejko%2C+Karol&rft.au=Catlin%2C+Oliver&rft.au=Stewart%2C+Timothy&rft.au=Muszy%C5%84ska%2C+Bo%C5%BCena&rft.date=2024-12-01&rft.eissn=1942-7611&rft.volume=16&rft.issue=12&rft.spage=1436&rft_id=info:doi/10.1002%2Fdta.3655&rft_id=info%3Apmid%2F38403950&rft_id=info%3Apmid%2F38403950&rft.externalDocID=38403950 |